SEC Form 4 · accession 0000899243-17-029150
Coherus Oncology, Inc. · CHRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis M Lanfear
Officer — See Remarks · Director
Period of report
Dec 15, 2017
Accepted (ET)
Dec 19, 2017 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001512762
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value | Dec 15, 2017 | A | 20,984 | $0.00 | A | 92,619 | D | |
| Common Stock, $0.0001 par valueF1 | holding | — | — | — | 1,337,566 | I | By Trust | |
| Common Stock, $0.0001 par valueF2 | holding | — | — | — | 86,965 | I | By LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee.
- F2These shares are held by Lanfear Capital Advisors, LLC of which Reporting Person is President.
Remarks
President and Chief Executive Officer